Definium Share Price

Definium Share Price

NASDAQ: DFTX | Mid Cap | Healthcare
$28.78
-$0.58 (-1.98%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • About
  • Price history
  • FAQs

Definium Stock Performance

Open
$29.36
Prev. Close
$29.36
Circuit Range
N/A
Day Range
$28.27 - $29.80
Year Range
$14.74 - $49.66
Volume
77,958
Average Traded
$28.89

Definium Share Price Today

As of 19 November 2026, Definium Therapeutics, Inc.'s share price is $28.78. The stock opened at $29.36, compared to its previous close of $29.36. During today's trading session, Definium Therapeutics, Inc.'s share price traded between $28.27 and $29.80, with an average price of $29.04. Over the past 52 weeks, the stock has recorded a high of $49.66 and a low of $14.74. In terms of performance, Definium Therapeutics, Inc.'s share price has risen by 19.07% over the last six months and is up 70.60% on a year-on-year basis.

Definium Share Price Chart

Line chart of the Definium price trend over the selected period. The price fell overall, ranging from 28.27 to 29.80, ending at 28.65.
$28.27$29.80
L
Show Current Price
H

Definium Stock Fundamentals & Key Indicators

Market Cap
$2.57B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.47
Revenue (TTM)
N/A
Return On Equity (TTM)
-34.86%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
N/A

Definium Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00
Net Profit-$77.10-$158.99-$50.96
Net Profit MarginN/AN/AN/A
Income ChangeN/A-106.21%67.95%

About Definium

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Definium Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$36.78
$28.71
-20.92%
Oct 2026
$37.83
$36.30
-4.76%
Sep 2026
$39.86
$38.12
-12.97%
Aug 2026
$42.56
$43.80
+0.69%
Jul 2026
$47.08
$43.50
-7.45%
Jun 2026
$24.24
$47.00
+94.46%
May 2026
$22.05
$24.17
+10.44%
Apr 2026
$19.50
$21.89
+15.85%
Mar 2026
$16.89
$18.89
+8.13%
Feb 2026
$16.98
$17.47
+3.56%
Jan 2026
$15.00
$16.87
N/A

Definium Share Price FAQs